These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 2346707)

  • 1. A staging of lymphomas: practical thoughts on impractical practices.
    Raubitschek A; Goffman T; Glatstein E
    J Natl Cancer Inst Monogr; 1990; (10):13-7. PubMed ID: 2346707
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Clinical staging of malignant lymphoma].
    Bongartz G; Peters PE
    Radiologe; 1987 Aug; 27(8):355-62. PubMed ID: 3310090
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Overview of lymphoma diagnosis and management.
    Matasar MJ; Zelenetz AD
    Radiol Clin North Am; 2008 Mar; 46(2):175-98, vii. PubMed ID: 18619375
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Which staging for malignant lymphomas?
    Cavalli F
    Biomed Pharmacother; 1982 Jan; 36(1):2-3. PubMed ID: 7126767
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Can we cure indolent lymphomas?
    Cabanillas F
    Clin Cancer Res; 1997 Dec; 3(12 Pt 2):2655-9. PubMed ID: 10068269
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thoughts on the surgical staging of lymphomas.
    Norton L
    Mt Sinai J Med; 1985 Mar; 52(3):185-8. PubMed ID: 3872999
    [No Abstract]   [Full Text] [Related]  

  • 7. Treatment of relapsed aggressive lymphomas: regimens with and without high-dose therapy and stem cell rescue.
    Hagemeister FB
    Cancer Chemother Pharmacol; 2002 May; 49 Suppl 1():S13-20. PubMed ID: 12042984
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Prognostic factors of malignant lymphomas].
    Oyama A; Morita K; Suchi T; Ota K
    Gan No Rinsho; 1988 Apr; 34(5):705-13. PubMed ID: 3260293
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Malignant lymphomas--review, classification and staging].
    Pfannmüller E
    Rontgenblatter; 1984 Feb; 37(2):46-50. PubMed ID: 6710028
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Surgeons: A Future Role in Clinical Trials?
    Rusch VW
    Oncologist; 1997; 2(3):V-VI. PubMed ID: 10388050
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of imaging to choose treatment.
    Fermé C; Vanel D; Ribrag V; Girinski T
    Cancer Imaging; 2005 Nov; 5 Spec No A(Spec No A):S113-9. PubMed ID: 16361126
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Primary thyroid lymphomas: clinicopathologic study of 30 cases and review of the literature].
    Michels JJ; Delcambre C; Marnay J; Denoux Y; Peny AM; Chasle J
    Ann Pathol; 2002 Feb; 22(1):10-7. PubMed ID: 11937995
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Malignant non-Hodgkin lymphomas--a review].
    Bruntsch U
    HNO; 1985 Nov; 33(11):481-4. PubMed ID: 4077587
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Closing Remarks.
    Reed E
    Oncologist; 1996; 1(4):276-277. PubMed ID: 10388002
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lymphoma: an update on evolving trends in staging and management.
    Dailey SH; Sataloff RT
    Ear Nose Throat J; 2001 Mar; 80(3):164-70. PubMed ID: 11269220
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Position emission tomography with or without computed tomography in the primary staging of Hodgkin's lymphoma.
    Hutchings M; Loft A; Hansen M; Pedersen LM; Berthelsen AK; Keiding S; D'Amore F; Boesen AM; Roemer L; Specht L
    Haematologica; 2006 Apr; 91(4):482-9. PubMed ID: 16585015
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Cervical adenopathies of malignant lymphomas and especially Hodgkin's disease].
    Kenis Y
    Acta Chir Belg; 1983; 83(2):107-13. PubMed ID: 6858533
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinical data and therapy of malignant non-Hodgkin's lymphoma of nasal cavity and paranasal sinuses (author's transl)].
    Löbe LP; Katenkamp D
    Laryngol Rhinol Otol (Stuttg); 1981 Jun; 60(6):334-7. PubMed ID: 6894956
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The multidisciplinary approach, a need in optimal management of lymphomas.
    Gyenes G
    Arch Geschwulstforsch; 1980; 50(6):556-62. PubMed ID: 7224811
    [No Abstract]   [Full Text] [Related]  

  • 20. The applicability and prognostic value of the new TNM classification system for primary cutaneous lymphomas other than mycosis fungoides and Sézary syndrome: results on a large cohort of primary cutaneous B-cell lymphomas and comparison with the system used by the Dutch Cutaneous Lymphoma Group.
    Senff NJ; Willemze R
    Br J Dermatol; 2007 Dec; 157(6):1205-11. PubMed ID: 17941944
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.